GSK951 is a selective Janus kinase 3 (JAK3) inhibitor within the small molecule kinase inhibitor class, developed to address immune-related conditions and severe combined immunodeficiency by modulating… Read more
GSK951 is a selective Janus kinase 3 (JAK3) inhibitor within the small molecule kinase inhibitor class, developed to address immune-related conditions and severe combined immunodeficiency by modulating specific cytokine signaling pathways. Laboratories rely on high-quality reference standards of this compound to support critical analytical workflows, including impurity profiling and method validation. The inclusion of stable isotope labelled compounds, such as the deuterated analog GSK951-d4, provides essential internal standards for quantitative analysis. These compounds are indispensable tools for ensuring accuracy during mass spectrometry and high-performance liquid chromatography procedures, facilitating the rigorous quality control required for drug substance characterization. By employing these precise reference materials, researchers and analytical chemists can maintain high standards of sensitivity and reproducibility throughout the lifecycle of pharmaceutical development and routine monitoring.